InvestorsHub Logo
Followers 17
Posts 792
Boards Moderated 0
Alias Born 06/15/2010

Re: None

Friday, 01/18/2013 2:37:29 PM

Friday, January 18, 2013 2:37:29 PM

Post# of 403618
Cellceutix Makes Breakthrough in Cancer Research by Activating p53, the "Guardian Angel of the Human Genome."

Dr. Emil Frei: "What Cellceutix is doing with Kevetrin can lead to a groundbreaking moment in the world of oncology..."

Clinical Trials at Dana-Farber and Beth Israel Deaconess / Harvard Cancer Centers.

-transcribed from the Cellceutix website.
http://cellceutix.com/